Romiplostim for Chemotherapy-Induced Thrombocytopenia (cit) in Solid Tumors: Two Phase Iii, International, Randomized Controlled Trials (rct)

Al-Samkari, H.Geredeli, C.Arslan, C.Korantzis, I.Dogu, G. G.Nechaeva, M.Salgado Fernandez, M.2023-06-162023-06-1620220923-75341569-8041https://doi.org/10.1016/j.annonc.2022.07.1931https://hdl.handle.net/20.500.14365/1060Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORK[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessRomiplostim for Chemotherapy-Induced Thrombocytopenia (cit) in Solid Tumors: Two Phase Iii, International, Randomized Controlled Trials (rct)Conference Object10.1016/j.annonc.2022.07.1931